Newsroom

The ARPA-H Investor Catalyst Hub issued a network survey to solicit feedback from key stakeholders on the reimbursement landscape for novel medical devices and diagnostics.

Belle.ai was awarded $3.5 million to develop an artificial intelligence (AI) solution designed to enable healthcare providers to remotely examine images of skin, ear, and throat disorders.

Please join us for a virtual onboarding webinar for all spokes on Thursday, September 11. You don’t need to be a new member to join!

To speed progress of robust and trustworthy technology, ARPA-H launched the ImagiNg Data EXchange (INDEX) program.

We explore how spoke members of the ARPA-H Investor Catalyst Hub can engage with the network and support ARPA-H program development.

Celebrating Nasdaq’s Wellness Week, ARPA-H Director Dr. Renee Wegrzyn joined Daré Bioscience President and CEO Sabrina Martucci Johnson in New York City to ring the closing bell at Nasdaq.

ARPA-H recently announced the launch of its ImagiNg Data EXchange (INDEX) program, which was directly informed by the results of the medical imaging data marketplace network survey.

Spoke members gathered in Atlanta last month to share ideas and foster collaboration.

ARPA-H recently revealed the 23 teams selected to receive funding through the Sprint for Women’s Health.

Twenty-three awardees have been selected by ARPA-H for the Sprint for Women’s Health to address critical unmet challenges in women’s health.

Just over a year ago, the Advanced Research Projects Agency for Health (ARPA-H) launched the Investor Catalyst (IC) Hub as part of ARPANET-H—a nationwide health innovation network.

Throughout October, we look forward to sharing highlights from the IC Hub’s first year and giving you a sneak peek at what’s to come in year two!